SEC Form 4 · accession 0001209191-15-084476

Karyopharm Therapeutics Inc. · KPTI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Dec 8, 2015

Accepted (ET)

Dec 10, 2015 · 4:12 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001503802

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Dec 8, 2015	M	2,556	$0.033	A	6,818	D
Common Stock	Dec 8, 2015	S	2,556	$15.0091	D	4,262	D
Common Stock	Dec 8, 2015	M	6,061	$0.033	A	10,323	D
Common Stock	Dec 8, 2015	S	6,061	$15.0091	D	4,262	D
Common Stock	Dec 8, 2015	M	2,121	$0.264	A	6,383	D
Common Stock	Dec 8, 2015	S	6,383	$15.0091	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F1	$0.033	Dec 8, 2015	M	2,556	D	—	Nov 4, 2020	Common Stock	2,556	0	D
Stock Option (Right to Buy)^F2	$0.033	Dec 8, 2015	M	6,061	D	—	Jan 20, 2021	Common Stock	6,061	0	D
Stock Option (Right to Buy)^F3	$0.264	Dec 8, 2015	M	2,121	D	—	Dec 13, 2021	Common Stock	2,121	6,099	D

F1This option, representing a right to purchase a total of 9,091 shares, vested as to 25% of the shares on November 5, 2011, and the remaining 75% of the shares vested in 36 equal monthly installments thereafter.
F2This option, representing a right to purchase a total of 6,061 shares, vested as to 25% of the shares on October 22, 2011, and the remaining 75% of the shares vested in 36 equal monthly installments thereafter.
F3This option, representing a right to purchase a total of 8,220 shares, vested as to 25% of the shares on December 12, 2012, with the remaining 75% vesting in 36 equal monthly installments thereafter.